A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate.

Source:http://linkedlifedata.com/resource/pubmed/id/7646913

Download in:

View as

General Info

PMID
7646913